Simona Bramante

779 total citations
12 papers, 601 citations indexed

About

Simona Bramante is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Simona Bramante has authored 12 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Simona Bramante's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Simona Bramante is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Simona Bramante collaborates with scholars based in Finland, United Kingdom and United States. Simona Bramante's co-authors include Akseli Hemminki, Anna Kanerva, Vincenzo Cerullo, Suvi Parviainen, Mari Hirvinen, Saila K. Pesonen, Sari Pesonen, Iulia Diaconu, Anniina Koski and Timo Joensuu and has published in prestigious journals such as Cancer Research, International Journal of Cancer and eLife.

In The Last Decade

Simona Bramante

11 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Bramante Finland	11	429	403	232	152	127	12	601
Margaret R. Duffy United Kingdom	14	500 1.2×	445 1.1×	386 1.7×	134 0.9×	83 0.7×	25	705
Víctor Cervera-Carrascón Finland	18	513 1.2×	597 1.5×	249 1.1×	245 1.6×	167 1.3×	40	761
Sandra Silva-Arrieta United States	7	147 0.3×	168 0.4×	223 1.0×	95 0.6×	30 0.2×	8	459
Angela Ullmann Germany	7	89 0.2×	295 0.7×	353 1.5×	63 0.4×	32 0.3×	7	605
Svitlana P. Grekova Germany	10	313 0.7×	236 0.6×	136 0.6×	68 0.4×	62 0.5×	14	438
Dongling Gao China	8	232 0.5×	257 0.6×	147 0.6×	113 0.7×	78 0.6×	22	401
Joshua D. Freedman United Kingdom	6	249 0.6×	314 0.8×	167 0.7×	114 0.8×	66 0.5×	7	402
Damiá Tormo Germany	9	86 0.2×	110 0.3×	167 0.7×	218 1.4×	9 0.1×	12	382
Weizhou Hou United States	9	278 0.6×	315 0.8×	168 0.7×	144 0.9×	61 0.5×	13	453
Tuuli Ranki Finland	16	559 1.3×	469 1.2×	402 1.7×	95 0.6×	186 1.5×	22	716

Countries citing papers authored by Simona Bramante

Since Specialization

Citations

This map shows the geographic impact of Simona Bramante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Bramante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Bramante more than expected).

Fields of papers citing papers by Simona Bramante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Bramante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Bramante. The network helps show where Simona Bramante may publish in the future.

Co-authorship network of co-authors of Simona Bramante

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Bramante. A scholar is included among the top collaborators of Simona Bramante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Bramante. Simona Bramante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Välimäki, Niko, Annukka Pasanen, Oskari Heikinheimo, et al.. (2018). Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. eLife. 7. 53 indexed citations

Siurala, Mikko, Riikka Havunen, Dipongkor Saha, et al.. (2016). Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma. Molecular Therapy. 24(8). 1435–1443. 43 indexed citations

Siurala, Mikko, Markus Vähä‐Koskela, Riikka Havunen, et al.. (2016). Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. OncoImmunology. 5(5). e1136046–e1136046. 16 indexed citations

Zafar, Sadia, Suvi Parviainen, Mikko Siurala, et al.. (2016). Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy. OncoImmunology. 6(2). e1265717–e1265717. 26 indexed citations

Bramante, Simona, Anniina Koski, Ilkka Liikanen, et al.. (2015). Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. OncoImmunology. 5(2). e1078057–e1078057. 36 indexed citations

Koski, Anniina, Simona Bramante, Anja Kipar, et al.. (2015). Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues. Molecular Therapy. 23(10). 1641–1652. 24 indexed citations

Bramante, Simona, Johanna K. Kaufmann, Ville Veckman, et al.. (2015). Abstract B51: Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans. Cancer Immunology Research. 3(10_Supplement). B51–B51.

Bramante, Simona, Johanna K. Kaufmann, Ville Veckman, et al.. (2015). Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: Results in vitro, in rodents and in humans. International Journal of Cancer. 137(7). 1775–1783. 41 indexed citations

Siurala, Mikko, Simona Bramante, Lotta Vassilev, et al.. (2014). Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma. International Journal of Cancer. 136(4). 945–954. 50 indexed citations

10.

Liikanen, Ilkka, Laura Ahtiainen, Mari Hirvinen, et al.. (2013). Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients. Molecular Therapy. 21(6). 1212–1223. 139 indexed citations

11.

Bramante, Simona, Anniina Koski, Anja Kipar, et al.. (2013). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer. 135(3). 720–730. 37 indexed citations

12.

Diaconu, Iulia, Vincenzo Cerullo, Mari Hirvinen, et al.. (2012). Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus. Cancer Research. 72(9). 2327–2338. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact